HOME » INVESTORS: NEWS RELEASES
2005 NEWS RELEASES
December 8, 2005
(PDF) -
MIGENIX Completes License Agreement for MX-594AN – Establishes Broad
Dermatology Alliance with Cutanea Life Sciences, Inc.
December 8, 2005 (PDF) -
MIGENIX Reports Second Quarter Fiscal 2006 Results
November 1, 2005 (PDF) - MIGENIX to Present at the Rodman & Renshaw
Techvest 7th Annual Healthcare Conference on November 8th
November 22, 2005 (PDF) -
MIGENIX Initiates Enrollment in Phase IIb Hepatitis C Clinical Study of
Celgosivir in Combination with PEGETRONTM
October 3, 2005
(PDF) -
MIGENIX Announces Management Change
September 29, 2005 (PDF) -
MIGENIX to present at 2005 UBS Global Life Sciences Conference in New York
City; CEO Message #16 Released
September 27, 2005 (PDF) -
MIGENIX Completes First Clinical Study of Celgosivir in Chronic Hepatitis C
Patients
September 7, 2005 (PDF) -
MIGENIX Reports First Quarter Fiscal 2006 Results
August 30, 2005
(PDF) -
MIGENIX Announces Initiation of MX-226 Phase III Clinical Study
August 11, 2005 (PDF) -
MIGENIX Receives Approval to Initiate MX-3253 Phase IIb Combination Study in
HCV Non-Responders
July 14, 2005 (PDF) -
MIGENIX Reports Fourth Quarter and Fiscal Year 2005 Financial Results
July 13, 2005 (PDF) -
MIGENIX and Schering-Plough Sign Agreement for MX-3253 Hepatitis C Drug
Development and License Option
June 27, 2005 (PDF) -
MIGENIX Announces Completion of FDA Special Protocol Assessment for
Confirmatory MX-226 Phase III Trial in Preventing Catheter-Related Infections
June 23, 2005 (PDF) -
MIGENIX Reports Effectiveness of MX-2401 in Pneumonia Model
May 31, 2005 (PDF) -
MIGENIX Completes Equity Offering
May 17, 2005 (PDF) -
MIGENIX Provides Update on Unit Offering
April 28, 2005 (PDF) -
MIGENIX Receives Approval to Initiate MX-4509 Phase I/II Study
April 8, 2005 (PDF) -
MIGENIX to Present Celgosivir Data for the Treatment of Hepatitis C at the
18th International Conference on Antiviral Research
April 6, 2005 (PDF) -
MIGENIX Files Preliminary Prospectus for Unit Offering
April 1, 2005 (PDF)
- MIGENIX Receives $9.3 Million Investment Commitment from Technology
Partnerships Canada
March 10, 2005 (PDF) -
MIGENIX Reports Third Quarter Fiscal Year 2005 Results
February 9, 2005 (PDF) - MIGENIX
Releases CEO Message – Provides Update On Major Clinical Programs
|
